Newsroom: News
Artificial intelligence to improve cancer diagnosis
As part of the European BigPicture project, Henning Müller and his team from the HES-SO Valais in Sierre are developing algorithms to improve cancer diagnosis. These technologies are of interest to certain hospitals, including Sion. Since February 2021, Henning Müller, head of the eHealth Unit at the Computer Science Institute of the HES-SO Valais-Wallis in Sierre, has […]
January 11, 2023
Women’s health company awarded 2022 Tell Award
The MSD Merck spin-off is the third win for Lucerne in the past five years Canton Lucerne – The women’s health-focused pharma company, Organon, has been awarded the 2022 Tell Award for its success and contribution as an innovative company in Switzerland. This marks the third Tell Award win for a Lucerne-based company in the […]
December 13, 2022
Global oncology company from Lucerne expands in North America
The Swiss oncology company opens its first office in Canada Canton Lucerne – The global oncology company is expanding into Canada, making its innovative cancer therapy available throughout its new location. Novocure is a commercial-stage oncology company dedicated to the advancement of TTF therapy (Tumor Treating Fields) for patients with solid tumors. The company pioneered […]
November 15, 2022
Geistlich Pharma expands in Switzerland and acquires US-based Lynch Biologics
International Swiss medtech continues to grow its global footprint Canton Lucerne – Gestlich Pharma, the world market leader in regenerative dentistry, has acquired the Tennessee-based US medtech company: Lynch Biologics. Geistlich Pharma and Lynch Biologics share a mission to advance new regenerative technologies in dentistry. The aim is to provide even better support for the […]
October 27, 2022
Authorized for use in the USA: Geistlich Pharma’s collagen membrane
Canton Lucerne / Canton Zurich – The Geistlich Nexo-Gide, the collagen membrane developed by Swiss-based regenerative medical device company, Geistlich Pharma, has obtained clearance from the US Food and Drug Administration (FDA). The Nexo-Gide supports healing processes for tendon and ligament injuries, increasing the probability for successful surgical procedures for severe tendon and ligament injuries. […]
November 4, 2021
Altoida: years ahead in Alzheimer’s disease identification
Canton Lucerne – “Understanding your brain health should be simple,” says Altoida, a US-based biomedical startup with operations in Lucerne, Switzerland. Altoida, a Texas-based precision neurology startup, is building the digital engine to power early Alzheimer’s disease identification and personalized brain analysis. Its medical device has the approval of both US and European medical authorities. […]
August 6, 2021
Improving elderly care at Lucerne’s iHomeLab with “iSens light”
Canton Lucerne – iSens light is a commercially available sensor detecting irregularities in an elderly person’s movement patterns at home. If irregularities are observed, a caretaker is alerted! The iHomeLab, based in Lucerne, Switzerland, has produced the iSens light, a sensor placed near the bed of a person in need of care that detects irregularities […]
July 2, 2021
Virtual Walking helps to ease “phantom pains”
Canton Lucerne — The Centre for Pain Medicine and Lucerne University of Applied Sciences and Arts have together developed a globally unique installation to help paraplegics manage phantom pains. The aim is for Virtual Walking to ease the burden on an overworked brain. Researchers from the Lucerne University of Applied Sciences and Arts (HSLU) in […]
June 10, 2021
Biomarkers for severe cases of COVID-19 discovered
Zurich – Researchers including a team from the University of Zurich have identified the first biomarkers that predict a severe case of COVID-19. This will help to provide the best possible care for affected patients. Furthermore, new research projects on therapies are now possible
May 7, 2021
Basel Area shapes future health innovations
A success factor for the Basel Area has been its steady transformation. From chemicals through the pharmaceutical industry to the broadly diversified life sciences cluster. Now we are witnessing the start of another change: in the direction of digital health, healthtech and personalized medicine.
April 23, 2021
Biggest successes in 2020 for biotechs in the Basel Area
Biotech companies in the Basel Area played a key role in the sector’s record performance in 2020. The latest Swiss Biotech Report has shown that they led the response to the coronavirus pandemic, received record levels of financing or were acquired by big pharma.
April 22, 2021
CeQur receives ‘Highest Financing Round’ to date for a European Medtech startup
Lucerne – The medical technology company CeQur has received 115 million dollars from investors. Credit Suisse Entrepreneur Capital and Endeavor Vision led this, the highest financing round to date for a European medtech.
April 14, 2021